Increased circulating resistin levels in early-onset breast cancer patients of normal body mass index correlate with lymph node negative involvement and longer disease free survival: a multi-center POSH cohort serum proteomics study.
Townsend, Paul A
AffiliationCancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton, UK
MetadataShow full item record
AbstractEarly-onset breast cancer (EOBC) affects about one in 300 women aged 40 years or younger and is associated with worse outcomes than later onset breast cancer. This study explored novel serum proteins as surrogate markers of prognosis in patients with EOBC.
CitationIncreased circulating resistin levels in early-onset breast cancer patients of normal body mass index correlate with lymph node negative involvement and longer disease free survival: a multi-center POSH cohort serum proteomics study. 2018, 20(1): 19 Breast Cancer Res
JournalBreast Cancer Research
- Interleukin 15 and Eotaxin correlate with the outcome of breast cancer patients vice versa independent of CTC status.
- Authors: Vilsmaier T, Heidegger HH, Schröder L, Trapp E, Zehni AZ, Rack B, Janni W, Mahner S, Weissenbacher T, Jeschke U, Mumm JN, SUCCESS Study Group.
- Issue date: 2021 Jan
- Elevated Resistin Gene Expression in African American Estrogen and Progesterone Receptor Negative Breast Cancer.
- Authors: Vallega KA, Liu N, Myers JS, Yu K, Sang QX
- Issue date: 2016
- Outcome after neoadjuvant chemotherapy in estrogen receptor-positive and progesterone receptor-negative breast cancer patients: a pooled analysis of individual patient data from ten prospectively randomized controlled neoadjuvant trials.
- Authors: van Mackelenbergh MT, Denkert C, Nekljudova V, Karn T, Schem C, Marmé F, Stickeler E, Jackisch C, Hanusch C, Huober J, Fasching PA, Blohmer JU, Kümmel S, Müller V, Schneeweiss A, Untch M, von Minckwitz G, Weber KE, Loibl S
- Issue date: 2018 Jan
- Outcomes of locally advanced breast cancer patients with ≥ 10 positive axillary lymph nodes.
- Authors: Koca E, Kuzan TY, Dizdar O, Babacan T, Sahin I, Ararat E, Altundag K
- Issue date: 2013
- Prospective observational study of breast cancer treatment outcomes for UK women aged 18-40 years at diagnosis: the POSH study.
- Authors: Copson E, Eccles B, Maishman T, Gerty S, Stanton L, Cutress RI, Altman DG, Durcan L, Simmonds P, Lawrence G, Jones L, Bliss J, Eccles D, POSH Study Steering Group.
- Issue date: 2013 Jul 3